SCHEMBL5313656

SCHEMBL5313656

CCCO/N=C(\COc1cc(C(=O)O)cc(C(F)(F)F)c1)c1cccc(Oc2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.44
NPC1 O15118 1/20 0.43
POLB P06746 1/20 0.43
CYP2C9 P11712 1/20 0.43
RAB9A P51151 1/20 0.43
FABP1 P07148 3/20 0.43
AKR1C3 P42330 1/20 0.43
PPARG P37231 3/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
NR4A2 P43354 1/20 0.41
PLA2G4B P0C869 1/20 0.40
ENPP2 Q13822 1/20 0.38
PPARA Q07869 1/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MAPT P10636 1/20 0.38
ALOX12 P18054 1/20 0.38
CCR6 P51684 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5313658 1.00 KMT2A (0.44) KMT2ANPC1POLBCYP2C9RAB9A
SCHEMBL5314935 0.92 P2RY1 (0.40) KMT2ANPC1POLBCYP2C9RAB9A
SCHEMBL5314934 0.92 P2RY1 (0.40) KMT2ANPC1POLBCYP2C9RAB9A
SCHEMBL5312903 0.87 KMT2A (0.59) KMT2ANPC1POLBCYP2C9RAB9A
SCHEMBL5312906 0.87 KMT2A (0.59) KMT2ANPC1POLBCYP2C9RAB9A
SCHEMBL14530963 0.86 KMT2A (0.47) KMT2ANPC1POLBCYP2C9RAB9A
SCHEMBL5311776 0.83 KMT2A (0.46) KMT2ANPC1POLBCYP2C9RAB9A
SCHEMBL5311769 0.83 KMT2A (0.46) KMT2ANPC1POLBCYP2C9RAB9A
SCHEMBL5310869 0.82 KMT2A (0.57) KMT2ANPC1POLBCYP2C9RAB9A
SCHEMBL5310865 0.82 KMT2A (0.57) KMT2ANPC1POLBCYP2C9RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007058504-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES, LTD. (KR) 2007-05-24 WO disclosed
WO-2007058504-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES, LTD. (KR) 2007-05-24 WO disclosed